PERSISTENCE OF CIRCULATING BLASTS AFTER ONE WEEK OF INTENSIVE REMISSION INDUCTION THERAPY CONFERS A POOR-PROGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

被引：0
|
作者：
GAJJAR, A
RIBEIRO, R
HANCOCK, M
RIVERA, G
MAHMOUD, H
SANDLUND, J
CRIST, W
PUI, CH
机构：
[1] UNIV TENNESSEE CTR HLTH SCI, MEMPHIS, TN 38163 USA
[2] ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A515 / A515
页数：1
相关论文
共 45 条
  • [21] HYPER-TRANSFUSION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) DURING INDUCTION THERAPY - RESULTS OF A RANDOMIZED PROSPECTIVE-STUDY
    RITTER, J
    VOIGT, D
    SCHELLONG, G
    BLUT, 1986, 53 (03): : 248 - 248
  • [22] PROLONGED ASPARAGINE (ASN) DEPLETION AFTER HIGH-DOSE ASPARAGINASE (HDA) THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    FALLER, DV
    BEARDSLEY, GP
    MIKITA, T
    SALLAN, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 156 - 156
  • [23] INFLUENCE OF INDIVIDUAL DOSE INTENSITY IN INTENSIVE THERAPY ON PROGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF 213 PATIENTS OF STUDY COALL-85
    GOBRECHT, O
    GOBEL, U
    GRAUBNER, U
    GUTJAHR, P
    SCHOCK, V
    SPAAR, HJ
    JANKASCHAUB, GE
    KLINISCHE PADIATRIE, 1992, 204 (04): : 230 - 235
  • [24] In vitro resistance to prednisolone is related to minimal residual disease (MRD) after induction therapy in childhood acute lymphoblastic leukemia (ALL)
    de Haas, V
    Kaspers, GJL
    Oosten, L
    Bresters, D
    Wijkhuijs, AJM
    van den Berg, H
    van der Schoot, CE
    LEUKEMIA, 2001, 15 (03) : 510 - 510
  • [25] In vitro resistance to predulsolone is related to minimal residual disease (MRD) after induction therapy in childhood acute lymphoblastic leukemia (ALL)
    de Haas, V
    Kaspers, GJL
    Oosten, L
    Bresters, D
    Wijkhuijs, AJM
    van Wering, ER
    van den Berg, H
    van der Schoot, CE
    LEUKEMIA, 2001, 15 (12) : 2014 - 2015
  • [26] A RANDOMIZED CONTROLLED-STUDY OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER INTENSIVE INDUCTION AND CONSOLIDATION THERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    OHNO, R
    TOMONAGA, M
    OHSHIMA, T
    MASAOKA, T
    ASOU, N
    OH, H
    NISHIKAWA, K
    KANAMARU, A
    MURAKAMI, H
    FURUSAWA, S
    HIRANO, M
    TSUBAKI, K
    IMAI, K
    UEDA, T
    KURAISHI, Y
    OGAWA, N
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1993, 58 (1-2) : 73 - 81
  • [27] DISAPPOINTING RESULTS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN 2ND REMISSION AFTER RELAPSES ON THERAPY
    SOUILLET, G
    LEVERGER, G
    BORDIGONI, P
    LEMERLE, S
    REIFFERS, J
    LAMAGNERE, JP
    PLOUVIER, E
    AUTOGREFFE, F
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 412 - 412
  • [28] One year maintenance therapy after autologous bone marrow transplantation (ABMT) in childhood acute lymphoblastic (ALL) and acute myeloblastic leukemia (AML)
    Zintl, F
    Fuchs, D
    Hermann, J
    Muller, A
    Sauerbrey, A
    Hempel, L
    Gruhn, B
    Hafer, R
    Fuller, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 350 - 350
  • [29] Prognostic-significance of minimal residual disease after intensive induction therapy in childhood B-lineage acute lymphoblastic leukemia.
    Gruhn, B
    Hongeng, S
    Yi, H
    Hancock, ML
    Rubnitz, JE
    Neale, GAM
    Kitchingman, GR
    BLOOD, 1997, 90 (10) : 1877 - 1877
  • [30] PROLONGED PERSISTENCE OF PCR-DETECTABLE MINIMAL RESIDUAL DISEASE AFTER DIAGNOSIS OR FIRST RELAPSE PREDICTS POOR OUTCOME IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    STEENBERGEN, EJ
    VERHAGEN, OJHM
    VANLEEUWEN, EF
    VANDENBERG, H
    BEHRENDT, H
    SLATER, RM
    VONDEMBORNE, AEGK
    VANDERSCHOOT, CE
    LEUKEMIA, 1995, 9 (10) : 1726 - 1734
12345